Lord, Abbett & Co’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-1,097,031
| Closed | -$34.7M | – | 668 |
|
2021
Q1 | $34.7M | Sell |
1,097,031
-2,087,457
| -66% | -$66.1M | 0.09% | 328 |
|
2020
Q4 | $148M | Buy |
3,184,488
+1,338,048
| +72% | +$62.1M | 0.39% | 63 |
|
2020
Q3 | $60.8M | Buy |
1,846,440
+69,311
| +4% | +$2.28M | 0.19% | 163 |
|
2020
Q2 | $48.8M | Buy |
1,777,129
+1,180,398
| +198% | +$32.4M | 0.17% | 189 |
|
2020
Q1 | $17.9M | Buy |
+596,731
| New | +$17.9M | 0.08% | 337 |
|